Table 1 Characteristics of enrolled patients (N = 616) (imputed data), stratified by terminal extubation.
Feature | All patients (N = 616) | Without terminal extubation N = 220 (35.7%) | Terminal extubation N = 396 (64.3%) | p value |
|---|---|---|---|---|
Characteristics of enrolled patients at baseline | ||||
Country | ||||
Canada | 355 (57.6%) | 66 (30.0%) | 289 (73.0%) | < 0.001** |
Czech Republic | 219 (35.6%) | 153 (69.5%) | 66 (16.7%) | |
Netherlands | 42 (6.8%) | 1 (0.5%) | 41 (10.4%) | |
Centre | ||||
Group 1 | 271 (44.0%) | 187 (85.0%) | 84 (21.2%) | < 0.001** |
Group 2 | 345 (56.0%) | 33 (15.0%) | 312 (78.8%) | |
Age | 65 (55.6, 74.6) | 66 (57, 75) | 64 (55, 74) | 0.14* |
Sex | ||||
Females | 233 (37.8%) | 94 (42.7%) | 139 (35.1%) | 0.061** |
Males | 383 (62.2%) | 126 (57.3%) | 257 (64.9%) | |
Chronic pre-existing medical condition | 507 (82.3%) | 197 (89.5%) | 310 (78.3%) | < 0.001** |
Cardiac arrest with resuscitation before study inclusion | 84 (13.6%) | 40.0 (18.2%) | 44.0 (11.1%) | 0.014** |
Admission diagnosis | ||||
Neurologic disorder | 303 (49.2%) | 66.0 (30.0%) | 237.0 (59.6%) | < 0.001** |
Respiratory failure | 94 (15.3%) | 45.0 (20.5%) | 49.0 (12.4%) | 0.008** |
Sepsis | 91 (14.8%) | 51.0 (23.2%) | 40.0 (10.1%) | < 0.001** |
Other | 128 (20.8%) | 58.0 (26.4%) | 71.0 (17.9%) | 0.014** |
Active malignancy† | 96.0 (15.6%) | 50.0 (22.7%) | 46.0 (11.6%) | < 0.001** |
Metastatic malignancy† | 30.0 (4.9%) | 14.0 (6.4%) | 16.0 (4.0%) | 0.2** |
BMI | 27 (24, 31) | 28 (23, 31) | 27 (24, 30) | 0.9* |
APACHE II score (1st 24 h at ICU) | 27 (22, 32) | 29 (22, 35) | 27 (22, 31) | 0.043* |
Characteristics of enrolled patients at WLST | ||||
GCS | 3 (3, 5) | 3 (3, 3) | 3 (3, 6) | < 0.001* |
Pupillary reflex | ||||
Present | 428 (69.5%) | 169 (76.8%) | 259 (65.4%) | 0.003** |
Absent | 188 (30.5%) | 51 (23.2%) | 137 (34.6%) | |
Cough reflex | ||||
Present | 449 (72.9%) | 161 (73.2%) | 288 (72.7%) | > 0.9** |
Absent | 167 (27.1%) | 59 (26.8%) | 108 (27.3%) | |
Ventilation mode | ||||
Support | 175 (28.4%) | 41 (18.6%) | 134 (33.8%) | < 0.001** |
Control | 441 (71.6%) | 179 (81.4%) | 262 (66.2%) | |
Respiratory rate [bpm] | 20 (16, 25) | 20 (18, 26) | 20 (15, 24) | 0.009* |
FiO2 [%] | 40 (30, 60) | 50 (35, 71) | 40 (30, 50) | < 0.00* |
PEEP [cmH2O] | 8 (6, 10) | 8 (6, 10) | 8 (5, 10) | 0.6* |
Peak inspiratory pressure [cmH2O] | 22 (18, 27) | 24 (18, 30) | 22 (18, 26) | < 0.001* |
Route | ||||
Endotracheal tube | 597 (96.9%) | 208 (94.5%) | 389 (98.2%) | 0.011* |
Tracheostoma | 19 (3.1%) | 12 (5.5%) | 7 (1.8%) | |
Mean arterial pressure [mmHg] | 73 (62, 90) | 65 (53, 76) | 79 (68, 96) | < 0.001* |
Heart rate [bpm] | 91 (75, 108) | 98 (80, 114) | 88 (74, 105) | < 0.001* |
Lactate [mmol L−1] | 1.8 (1, 3.8) | 3.0 (1.3, 10.2) | 1.5 (1.0, 2.3) | < 0.001* |
pH (arterial) | 7.39 (7.28;7.45) | 7.31 (7.20, 7.40) | 7.42 (7.36, 7.46) | < 0.001* |
pO2 [mmHg] (arterial) | 95 (76, 118) | 90 (71, 107) | 100 (80, 128) | < 0.001* |
pCO2 [mmHg] (arterial) | 39 (34, 45) | 41 (34, 48) | 38 (34, 43) | 0.008* |
Total ranked dose of circulatory drugs | 0.05 (0, 0.61) | 0.59 (0.06, 0.86) | 0 (0, 0.25) | < 0.001* |
Patients with circulatory drugs† | 325.0 (52.8%) | 171.0 (77.7%) | 154.0 (38.9%) | < 0.001** |
Total ranked dose of circulatory drugs (only patients with circulatory drugs)† | 0.59 (0.26, 0.85) | 0.71 (0.45, 0.92) | 0.36 (0.18, 0.74) | < 0.001* |
Total ranked dose of sedatives | 0 (0, 0.37) | 0 (0, 0.31) | 0 (0, 0.42) | 0.2* |
Patients with sedatives† | 270.0 (43.8%) | 88.0 (40.0%) | 182.0 (46.0%) | 0.2** |
Total ranked dose of sedatives (only patients with sedatives)† | 0.47 (0.22, 0.81) | 0.44 (0.23, 0.79) | 0.47 (0.20, 0.81) | > 0.9 |
Total ranked dose of opioids | 0.04 (0, 0.49) | 0 (0, 0.45) | 0.10 (0, 0.51) | 0.051* |
Patients with opioids† | 313.0 (50.8%) | 100.0 (45.5%) | 213.0 (53.8%) | 0.047** |
Total ranked dose of opioids (only patients with opioids)† | 0.48 (0.26, 0.80) | 0.48 (0.25, 0.80) | 0.49 (0.26, 0.79) | 0.7* |
Eligible for donation after circulatory death† | 307.0 (49.8%) | 68.0 (30.9%) | 239.0 (60.4%) | < 0.001** |
Attempted donation after circulatory death | 87 (14.1%) | 4 (1.8%) | 83 (21.0%) | < 0.001* |
Successful donation after circulatory death | 60 (9.7%) | 4 (1.8%) | 56 (14.1%) | < 0.001* |